Results 161 to 170 of about 24,569 (232)

Antifibrotic effects of 2-carba cyclic phosphatidic acid (2ccPA) in systemic sclerosis: contribution to the novel treatment. [PDF]

, 2019
HIGUCHI Tomoaki, ICHIMURA Yuki, KATSUMATA Yasuhiro, KAWAGUCHI Yasushi, MASUDA Ikuko, MOROHOSHI Toshiro, NOROSE Takanari, TAKAGI Kae, TOCHIMOTO Akiko, YAMANAKA Hisashi   +9 more
core   +2 more sources

Effects of a Bioactive Vegetable-Enriched Diet on Autotaxin and Liver Fibrosis in MASLD with Evidence of Sex-Specific Responses: A Pilot Study. [PDF]

Nutrients
Cerabino N, Bonfiglio C, Bonfrate L, Pesole PL, Stabile D, Shahini E, Di Chito M, De Pergola G, Giannelli G.   +8 more
europepmc   +1 more source

LYSOPHOSPHATIDIC ACID RECEPTOR SIGNALING AND FUNCTION IN OSTEOBLASTS

, 2011
Osteoblasts form bone and regulate the activity of other bone cells. Lysophosphatidic acid (LPA) is a lipid mediator that, in other systems, stimulates cell proliferation, survival and migration. We investigated LPA signaling and function in osteoblasts. Transcripts encoding multiple LPA receptors were identified.
openaire   +1 more source

Neutrophils as key drivers of pulmonary fibrosis: unveiling mechanisms and therapeutic implications. [PDF]

Front Immunol
Liang X, Li Y, Tang Z, Luo Y, Liu Y.
europepmc   +1 more source

Lysophosphatidic acid signaling: Transmembrane modulators in the central nervous system. [PDF]

Neural Regen Res
Polyzou A, Tsiouris AK, Labrakakis C, Eickholt BJ, Leondaritis G.   +4 more
europepmc   +1 more source

The neuro-immune insights of itch: peripheral mechanisms and central glial contributions. [PDF]

Cell Mol Biol Lett
Li Z, Yu N, Feng S, Wang X, Chu YX, Liu X.   +5 more
europepmc   +1 more source

Identify GDPD3 as a key regulator of epithelial-mesenchymal transition and prostate adenocarcinoma progression via the LPA/LPAR1/AKT axis: transcriptomic and experimental study. [PDF]

Front Immunol
Hao L, Chen X, He T, Wu T, Wen Z, Ji Z, Zheng X, Zheng Q, Zhou Q, He C, Long Q, Sun D.   +11 more
europepmc   +1 more source

Role of Growth Factors in the Pathogenesis of Systemic-Sclerosis-Associated Fibrosis. [PDF]

Int J Mol Sci
Mendoza FA, Piera-Velazquez S, Jimenez SA.   +2 more
europepmc   +1 more source

Glial Activation, Neuroinflammation, and Loss of Neuroprotection in Chronic Pain: Cellular Mechanisms and Emerging Therapeutic Strategies. [PDF]

Biomedicines
McKenzie A, Dombrower R, Theeraphapphong N, McKenzie S, Hijazin MA.   +4 more
europepmc   +1 more source

Levodopa and the dopamine receptor D1-Hippo/yes-associated protein axis: A novel therapeutic avenue for liver fibrosis. [PDF]

World J Gastroenterol
Xie SS, Liu ZG.
europepmc   +1 more source